Obermeyer Wealth Partners Has $39.75 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Obermeyer Wealth Partners decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 75,902 shares of the healthcare conglomerate's stock after selling 3,074 shares during the period. UnitedHealth Group makes up 2.1% of Obermeyer Wealth Partners' portfolio, making the stock its 15th largest holding. Obermeyer Wealth Partners' holdings in UnitedHealth Group were worth $39,754,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Fagan Associates Inc. raised its holdings in UnitedHealth Group by 2.8% during the 1st quarter. Fagan Associates Inc. now owns 6,017 shares of the healthcare conglomerate's stock worth $3,151,000 after purchasing an additional 165 shares during the last quarter. 1776 Wealth LLC grew its stake in shares of UnitedHealth Group by 4.3% during the 1st quarter. 1776 Wealth LLC now owns 2,455 shares of the healthcare conglomerate's stock worth $1,286,000 after acquiring an additional 102 shares in the last quarter. Clifford Swan Investment Counsel LLC grew its stake in shares of UnitedHealth Group by 15.0% during the 1st quarter. Clifford Swan Investment Counsel LLC now owns 57,518 shares of the healthcare conglomerate's stock worth $30,125,000 after acquiring an additional 7,499 shares in the last quarter. Gries Financial LLC grew its stake in shares of UnitedHealth Group by 176.7% during the 1st quarter. Gries Financial LLC now owns 4,956 shares of the healthcare conglomerate's stock worth $2,596,000 after acquiring an additional 3,165 shares in the last quarter. Finally, Crestwood Advisors Group LLC boosted its holdings in shares of UnitedHealth Group by 29.2% in the 1st quarter. Crestwood Advisors Group LLC now owns 5,357 shares of the healthcare conglomerate's stock valued at $2,806,000 after buying an additional 1,210 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Mizuho cut their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Bank of America downgraded UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Morgan Stanley lowered their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. KeyCorp lowered their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Finally, JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research report on Friday, June 20th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $394.43.

UnitedHealth Group Trading Up 0.5%

Shares of UnitedHealth Group stock traded up $1.47 during midday trading on Monday, reaching $284.12. The company had a trading volume of 2,090,131 shares, compared to its average volume of 7,797,686. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a fifty day moving average price of $304.47 and a 200 day moving average price of $432.39. The firm has a market cap of $257.74 billion, a PE ratio of 11.90, a P/E/G ratio of 1.38 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.11%. UnitedHealth Group's payout ratio is currently 37.02%.

Insider Activity

In related news, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director directly owned 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.